-
-
Data highlights need for more preventative care for MS patients
-
10th Feb 2020
-
Posted in Industry News
- Service News: hospital admissions for MS patients on the rise.
-
-
Neurology Courses for Trainees: A 2020 Update
-
7th Feb 2020
-
Posted in Association of British Neurologists Trainees,Courses & Conferences
- Amy Ross Russell and Angelika Zarkali
-
-
First Publication of Real-World Data Showing Translarna (ataluren) Significantly Preserves Ability to Walk for Longer in Children with Duchenne Muscular Dystrophy
-
5th Feb 2020
-
Posted in Industry News
- Industry news from PTC Therapeutics
-
-
Origins of Vertigo
-
5th Feb 2020
-
Posted in History
- JMS Pearce
-
-
Advertiser’s event preview: Naidex 46
-
31st Jan 2020
-
Posted in Courses & Conferences
- Advertiser's event preview: Naidex 46
-
-
NEURAM2020: Improving neuro-rehabilitative care in Mauritius
-
27th Jan 2020
-
Posted in Courses & Conferences
- Conference details: 27-28 May 2020
-
-
Type 1 Spinal Muscular Atrophy: Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants
-
23rd Jan 2020
-
Posted in Industry News
- News from PTC therapeutics
-
-
New mobile scanner allows CT images of the head directly on the ICU ward
-
23rd Jan 2020
-
Posted in Industry News
- News from Siemens
-
-
Neurokinex Kids brings breakthrough therapies to children with Cerebral Palsy
-
22nd Jan 2020
-
Posted in Industry News
- Industry news from Neurokinex
-
-
EU approval of Mayzent® (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease
-
21st Jan 2020
-
Posted in Industry News
- News from Novartis on the EU approval of Mayzent (siponimod) for adult patients with SPMS with active disease
